Maximising adherent cell production via customisable and dissolvable bio-polymer microcarriers
Biomedical Materials · 2025
DOI: 10.1088/1748-605x/adf1cd ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2025. Verfasst von Timothy R Cox und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia. Hauptthemen laut MEDLINE: Polymers, Cell Culture Techniques, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Large-scale cellular production systems offer a significant and diverse benefit impacting the therapeutic (stem cell and vaccine production) and cellular agriculture (lab-grown meat) sectors. Producing desired cells at mass can improve production yield whilst reducing the environmental and ethical burden associated with industrialised agriculture and production of therapeutic goods. Many existing large-scale cultivation strategies of adherent cells leverage the use of microcarriers (MCs) within bioreactors. However, currently commercial MCs are not dissolvable and lack specificity for different cell types and bioprocessing contexts. In this work, we validate the effectiveness of customisable, polymeric MCs engineered to enhance cell growth and productivity. These MCs, which can be adjusted in terms of stiffness, surface charge, and size, maintain their structural integrity while offering precise property modifications. Under specific bioprocessing conditions, the custom MCs demonstrated significant improvements in cell productivity and sustainability compared to other commercial options. Our study (1) highlights how tailored substrate properties, particularly stiffness, can significantly impact cell yield and outcomes, and (2) suggests additional optimisations in surface charge and size that could further enhance MC technology. These advancements have the potential to improve large-scale cell and virus production efficiency, ultimately reducing the cost of production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.
- Smart MCs Pty Ltd, 8/13B Narabang Way, Belrose, Sydney, NSW 2085, Australia.
- Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia.
- Bioprocessing Technology Institute, 20 Biopolis Way, Centros #06-01, Singapore 138668, Singapore.
- Guangdong Hitide Biotechnology Co., Ltd, Guangzhou, Guangzhou 510630, People's Republic of China.
- School of Life and Environmental Sciences, University of Sydney, Camperdown, NSW 2050, Australia.
ORCID-Profile: Christopher J O'Keeffe, Alan Lam, Thomas H Roberts, Khoon S Lim, Steve Kw Oh, Payar Radfar, Majid Ebrahimi Warkiani, Lin Ding
Zitieren
APA
Cox, T. R., Lesmana, D., O'Keeffe, C. J., Lam, A., Zou, W., Lin, Z., Lin, X., Roberts, T. H., Lim, K. S., Oh, S. K., Radfar, P., Ebrahimi Warkiani, M., & Ding, L. (2025). Maximising adherent cell production via customisable and dissolvable bio-polymer microcarriers. Biomedical Materials. https://doi.org/10.1088/1748-605x/adf1cd
Vancouver
Cox TR, Lesmana D, O'Keeffe CJ, Lam A, Zou W, Lin Z, et al. Maximising adherent cell production via customisable and dissolvable bio-polymer microcarriers. Biomedical Materials. 2025. doi:10.1088/1748-605x/adf1cd
BibTeX
@article{Cox2025,
author = {Cox, Timothy R and Lesmana, David and O'Keeffe, Christopher J and Lam, Alan and Zou, Weibin and Lin, Zidong and Lin, Xuye and Roberts, Thomas H and Lim, Khoon S and Oh, Steve Kw and Radfar, Payar and Ebrahimi Warkiani, Majid and Ding, Lin},
title = {Maximising adherent cell production via customisable and dissolvable bio-polymer microcarriers},
journal = {Biomedical Materials},
year = {2025},
doi = {10.1088/1748-605x/adf1cd}
}
EUVIMED